Also read: Money 20/20 Recap: Ethereum, Consumer Protection, Investment Overstock Moving Forward With t0 Starting on December 15th, individuals who purchased Overstock shares by the November 7th record date will qualify to
purchase shares of its preferred stock, including preferred shares to be issued and traded
Not exact matches
From July 2012 through September 2012, the Registrant sold an aggregate
of 20,164,210
shares of its Series D convertible
preferred stock to 21 accredited investors at a
purchase price
of approximately $ 11.014 per
share, for an aggregate
purchase price
of approximately $ 222.1 million.
Warrant to
purchase shares of convertible
preferred stock issued to TriplePoint Capital LLC, dated as
of March 17, 2010.
As
of September 30, 2014, the holders
of 52,132,350
shares of our common
stock, including our common
stock issuable in connection with the automatic conversion
of all outstanding
shares of our convertible
preferred stock into
shares of our common
stock and the holder
of a warrant to
purchase 6,500,000
shares of our common
stock, are entitled to rights with respect to the registration
of their
shares following this offering under the Securities Act.
This convertible
preferred stock warrant will become a warrant to
purchase shares of our common
stock upon the closing
of this offering.
In January 2014, we sold an aggregate
of 1,332,640
shares of Series C
preferred stock to a total
of three accredited investors at a
purchase price per
share of $ 3.40893 for an aggregate
purchase price
of $ 4,542,876.
the conversion
of all outstanding warrants to
purchase shares of convertible
preferred stock into warrants to
purchase the same number
of shares of Class B common
stock immediately prior to the completion
of this offering;
In May 2015, we sold an aggregate
of 1,367,187
shares of Series F
preferred stock to a total
of four accredited investors at a
purchase price
of $ 30.72 for an aggregate
purchase price
of $ 41,999,985.
In October 2014, we sold an aggregate
of 2,394,569
shares of Series E
preferred stock to a total
of two accredited investors at a
purchase price per
share of $ 21.7158 for an aggregate
purchase price
of $ 51,999,981.
Between June 2013 and August 2013, the Registrant issued and sold to six accredited investors an aggregate
of 19,433,258
shares of Series D convertible
preferred stock, at a
purchase price
of $ 2.21 per
share, for aggregate consideration
of $ 42,999,970.
In September 2012, the Registrant issued warrants to
purchase 1,080,000
shares of its Series C convertible
preferred stock at an exercise price
of $ 1.00 per
share to two accredited investors.
In May 2009, we completed our Series E financing in which $ 50.0 million
of proceeds was received for the
purchase of 19,901,290
shares of Series E convertible
preferred stock at a price
of $ 2.51 per
share.
In connection with this offering, the warrants to
purchase shares of our Series B and Series C convertible
preferred stock will convert automatically into warrants to
purchase a like number
of shares of our Class B common
stock.
In connection with this financing, the remaining holders
of the February 2008 notes and warrants converted their notes into
shares of Series E convertible
preferred stock and warrants to
purchase 866,091
shares of Series E convertible
preferred stock.
In February 2008, the registrant issued warrants to
purchase an aggregate
of 866,091
shares of the registrant's Series E
preferred stock to 19 accredited investors at an exercise price
of $ 2.5124 per
share.
In March 2016, we sold an aggregate
of 334,471
shares of Series F
preferred stock to a total
of two accredited investors at a
purchase price
of $ 30.72 for an aggregate
purchase price
of $ 10,274,949.
In May 2016, we sold an aggregate
of 22,780,982
shares of Series F
preferred stock to a total
of 97 accredited investors at a
purchase price
of $ 30.72 for an aggregate
purchase price
of $ 699,831,767.
In July 2014, we sold an aggregate
of 1,013,085
shares of Series E
preferred stock to a total
of five accredited investors at a
purchase price per
share of $ 21.7158 for an aggregate
purchase price
of $ 21,999,951.
In December 2014, we sold an aggregate
of 4,186,629
shares of Series E
preferred stock to a total
of three accredited investors at a
purchase price
of $ 21.7158 per
share for an aggregate
purchase price
of $ 90,915,998.
However, in January 2010, we issued a warrant to the DOE in connection with the closing
of the DOE Loan Facility to
purchase shares of our Series E convertible
preferred stock.
Upon the completion
of this offering, we expect that the convertible
preferred stock warrants currently outstanding will either be exercised or become warrants to
purchase shares of our common
stock.
In February 2016, we sold an aggregate
of 5,696,615
shares of Series F
preferred stock to a total
of 14 accredited investors at a
purchase price
of $ 30.72 for an aggregate
purchase price
of $ 175,000,013.
In July 2015, we sold an aggregate
of 3,678,383
shares of Series F
preferred stock to a total
of six accredited investors at a
purchase price
of $ 30.72 for an aggregate
purchase price
of $ 112,999,926.
In November 2014, we sold an aggregate
of 4,604,942
shares of Series E
preferred stock to a total
of five accredited investors at a
purchase price per
share of $ 21.7158 for an aggregate
purchase price
of $ 99,999,999.
The tender offer was completed on March 4, 2013 with a total
of $ 59.6 million worth
of shares of our common
stock and Class A junior
preferred stock being
purchased.
During July 2011, we sold an aggregate
of 10,097,159
shares of our Series G - 1 convertible
preferred stock to two accredited investors at a
purchase price
of approximately $ 16.09 per
share, for an aggregate
purchase price
of $ 162,499,987.
The
purchase price per
share in the tender offer represented an excess to the fair value
of the Company's outstanding common
stock and Series A through Series F convertible
preferred stock, as determined by the Company's most recent valuation
of its capital
stock at time
of the transaction.
In 2011, the investors in our Series G convertible
preferred stock financing commenced a tender offer to
purchase shares of our common
stock and Series A through Series F convertible
preferred
Parity Parity price Participating
preferred stock Participating (semi-fixed) Trusts Partnership Par value Passive income Pass - through security Payment date P / E ratio Penny
stocks PHA Bonds Phantom income Pink sheets Placement Ratio Plan completion life insurance PN Point Portfolio income Position limits Positions book Pot Power
of attorney Pre-dispute arbitration clause Preemptive right
Preferred stock Preliminary prospectus Preliminary study Preliminary statement Premium Pre-refunding Pre-sale order Price to Earnings ratio Primary distribution Primary market Prime rate Principal Principal stockholder Principal transactions Private placement Private placement memorandum Private securities transaction Proceeds sale Production
purchase program Profile Profit -
sharing plans Program trading Progressive tax Project note Prospectus Prospectus delivery period Proxy Prudent Man Rule Public float value Public Housing Authority Bonds Public Offering Public offering price Purchaser's representative Put bond Put option Put spread
He only needs to place an order with the broker indicating the number
of shares to
purchase and the specific
stock preferred.
Instead
of just buying
shares the old fashioned way (through common or
preferred shares), you could
purchase stock options, which, quite obviously by the name, gives you the option to buy the
stock.
The equity securities in which the Fairholme Fund may invest include common and
preferred stock (including convertible
preferred stock), partnership interests, business trust
shares, interests in real estate investment trusts («REITs»), rights and warrants to subscribe for the
purchase of equity securities, and depository receipts.
Related Hedges: The
purchase of convertible bonds or convertible
preferred shares, and the simultaneous sale
of the common
stock into which they were exchangeable.
When a buyer
purchases a company in the private market, he has to pay for the company equity (including common
stock,
preferred shares, minority interest, etc), he has to pay off all the debt, but in return the buyer gets the cash the company has in its bank accounts and other cash equivalents in form
of securities and other liquid assets.
* CONTRAVIR PHARMACEUTICALS FILES FOR SERIES C CONVERTIBLE
PREFERRED STOCK AND WARRANTS TO
PURCHASE SHARES OF COMMON
STOCK OF UP TO $ 20 MILLION - SEC FILING Source text: (https://bit.ly/2wUNyv5) Further company coverage:
Feldman will issue 2 million
shares at $ 25 per
share,
of which Inland American intends to
purchase $ 15 million in
preferred stock by April 30 and the remaining $ 35 million within 12 months
of the first
stock purchase.
Feldman will issue 2 million
shares at $ 25,
of which Inland American intends to
purchase $ 15 million in
preferred stock by April 30 and the remaining $ 35 million within 12 months
of the first
stock purchase.